These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21907303)

  • 1. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections.
    Metan G; Koc AN; Ağkuş Ç; Kaynar LG; Alp E; Eser B
    Rev Iberoam Micol; 2012; 29(3):169-71. PubMed ID: 21907303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
    Metan G; Ağkuş C; Buldu H; Koç AN
    Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does ampicillin-sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections.
    Metan G; Agkus C; Nedret Koc A; Elmali F; Finkelman MA
    Mycoses; 2012 Jul; 55(4):366-71. PubMed ID: 22040530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of the 1,3-β-D-glucan assay during bacteraemia: limited evidence from a prospective study.
    Racil Z; Kocmanova I; Toskova M; Winterova J; Lengerova M; Timilsina S; Mayer J
    Mycoses; 2013 Mar; 56(2):101-4. PubMed ID: 22594314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.
    He S; Hang JP; Zhang L; Wang F; Zhang DC; Gong FH
    J Microbiol Immunol Infect; 2015 Aug; 48(4):351-61. PubMed ID: 25081986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What should be the optimal cut-off of serum 1,3-β-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?
    Metan G; Koç AN; Atalay A; Kaynar LG; Ozturk A; Alp E; Eser B
    Scand J Infect Dis; 2012 May; 44(5):330-6. PubMed ID: 22188426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.
    Giacobbe DR; Mikulska M; Tumbarello M; Furfaro E; Spadaro M; Losito AR; Mesini A; De Pascale G; Marchese A; Bruzzone M; Pelosi P; Mussap M; Molin A; Antonelli M; Posteraro B; Sanguinetti M; Viscoli C; Del Bono V;
    Crit Care; 2017 Jul; 21(1):176. PubMed ID: 28693606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
    White SK; Schmidt RL; Walker BS; Hanson KE
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.
    Reischies FM; Prattes J; Woelfler A; Eigl S; Hoenigl M
    Transpl Infect Dis; 2016 Jun; 18(3):466-70. PubMed ID: 26992092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
    Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
    Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of β-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy.
    Guitard J; Tabone MD; Senghor Y; Cros C; Moissenet D; Markowicz K; Valin N; Leverger G; Hennequin C
    J Infect; 2016 Dec; 73(6):607-615. PubMed ID: 27452196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
    Alam FF; Mustafa AS; Khan ZU
    BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.
    Prattes J; Hoenigl M; Rabensteiner J; Raggam RB; Prueller F; Zollner-Schwetz I; Valentin T; Hönigl K; Fruhwald S; Krause R
    Mycoses; 2014 Nov; 57(11):679-86. PubMed ID: 25040144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of activated platelet-dependent chemokines and soluble cell adhesion molecules in patients with hematologic malignancies and high levels of beta-D-glucan.
    Nomura S; Iishii K; Inami N; Kimura E; Urase F
    Pathophysiol Haemost Thromb; 2007; 36(1):32-9. PubMed ID: 18332612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
    Zeng SY; Liu T; Meng WT; Chen YN
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections.
    Albert O; Toubas D; Strady C; Cousson J; Delmas C; Vernet V; Villena I
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1453-60. PubMed ID: 21479838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of (1→3)-β-D-glucan in same-day urine and serum samples obtained from patients with haematological malignancies.
    Raggam RB; Fischbach LM; Prattes J; Duettmann W; Eigl S; Reischies F; Wölfler A; Rabensteiner J; Prueller F; Krause R; Hoenigl M
    Mycoses; 2015 Jul; 58(7):394-8. PubMed ID: 25959065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent false-positive results of Aspergillus latex agglutination test: transient Aspergillus antigenemia during neutropenia.
    Kami M; Kanda Y; Ogawa S; Mori S; Tanaka Y; Honda H; Chiba S; Mitani K; Yazaki Y; Hirai H
    Cancer; 1999 Jul; 86(2):274-81. PubMed ID: 10421263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.